Spada M et al. |
Randomized trial of basiliximab induction versus steroid therapy in pediatric liver allograft recipients under tacrolimus immunosuppression. |
2006 |
Am. J. Transplant. |
pmid:16771811
|
Donners MM et al. |
Low-dose FK506 blocks collar-induced atherosclerotic plaque development and stabilizes plaques in ApoE-/- mice. |
2005 |
Am. J. Transplant. |
pmid:15888024
|
Lehmann R et al. |
Successful simultaneous islet-kidney transplantation using a steroid-free immunosuppression: two-year follow-up. |
2004 |
Am. J. Transplant. |
pmid:15196070
|
Lemahieu W et al. |
Cytochrome P450 3A4 and P-glycoprotein activity and assimilation of tacrolimus in transplant patients with persistent diarrhea. |
2005 |
Am. J. Transplant. |
pmid:15888045
|
Axelrod D et al. |
Reduction of CMV disease with steroid-free immunosuppresssion in simultaneous pancreas-kidney transplant recipients. |
2005 |
Am. J. Transplant. |
pmid:15888050
|
Reyes J et al. |
Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin). |
2005 |
Am. J. Transplant. |
pmid:15888051
|
Knoop C et al. |
Tacrolimus pharmacokinetics and dose monitoring after lung transplantation for cystic fibrosis and other conditions. |
2005 |
Am. J. Transplant. |
pmid:15888057
|
Kandaswamy R et al. |
A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients--an interim analysis. |
2005 |
Am. J. Transplant. |
pmid:15888064
|
Saliba F et al. |
Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized Trial. |
2017 |
Am. J. Transplant. |
pmid:28133906
|
Cosio FG and Larson TS |
Cardiovascular disease after transplantation: do we know all of the variables? |
2003 |
Am. J. Transplant. |
pmid:12859523
|
Levitsky J and Feng S |
Sirolimus and mTOR inhibitors in liver transplantation: the wheel has come full circle. |
2014 |
Am. J. Transplant. |
pmid:24620373
|
Campbell PM et al. |
Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation. |
2007 |
Am. J. Transplant. |
pmid:17456201
|
de Fijter JW et al. |
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial. |
2017 |
Am. J. Transplant. |
pmid:28027625
|
Krämer BK et al. |
Cardiovascular risk factors and estimated risk for CAD in a randomized trial comparing calcineurin inhibitors in renal transplantation. |
2003 |
Am. J. Transplant. |
pmid:12859533
|
Ciancio G et al. |
The use of daclizumab, tacrolimus and mycophenolate mofetil in african-american and Hispanic first renal transplant recipients. |
2003 |
Am. J. Transplant. |
pmid:12859538
|
Singh K et al. |
Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer. |
2014 |
Am. J. Transplant. |
pmid:25359003
|
Dugast E et al. |
Failure of Calcineurin Inhibitor (Tacrolimus) Weaning Randomized Trial in Long-Term Stable Kidney Transplant Recipients. |
2016 |
Am. J. Transplant. |
pmid:27367750
|
Tang Q |
Pharmacokinetics of therapeutic Tregs. |
2014 |
Am. J. Transplant. |
pmid:25358900
|
Wen X et al. |
Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients. |
2016 |
Am. J. Transplant. |
pmid:27137884
|
Trofe-Clark J et al. |
Immunosuppression, generic drugs and the FDA. |
2012 |
Am. J. Transplant. |
pmid:22176626
|
Sikma MA et al. |
Pharmacokinetics and Toxicity of Tacrolimus Early After Heart and Lung Transplantation. |
2015 |
Am. J. Transplant. |
pmid:26053114
|
Latran M |
Response to Klintmalm on the use of generic immunosuppression. |
2012 |
Am. J. Transplant. |
pmid:22176636
|
Ellis CL and Racusen LC |
Mild rise in creatinine six months post kidney transplant. |
2012 |
Am. J. Transplant. |
pmid:22845913
|
Abdelmalek MF et al. |
Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial. |
2012 |
Am. J. Transplant. |
pmid:22233522
|
Boudjema K et al. |
Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study. |
2011 |
Am. J. Transplant. |
pmid:21466650
|
Knechtle SJ |
Guidance for liver transplant immunosuppression. |
2011 |
Am. J. Transplant. |
pmid:21466652
|
Krenzien F et al. |
Age-Dependent Metabolic and Immunosuppressive Effects of Tacrolimus. |
2017 |
Am. J. Transplant. |
pmid:27754593
|
Gupta G et al. |
Safe Conversion From Tacrolimus to Belatacept in High Immunologic Risk Kidney Transplant Recipients With Allograft Dysfunction. |
2015 |
Am. J. Transplant. |
pmid:25988397
|
Saikali JA et al. |
Sirolimus may promote thrombotic microangiopathy. |
2003 |
Am. J. Transplant. |
pmid:12603218
|
Duncan FJ et al. |
Clinically relevant immunosuppressants influence UVB-induced tumor size through effects on inflammation and angiogenesis. |
2007 |
Am. J. Transplant. |
pmid:17941958
|
Suszynski TM et al. |
Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation. |
2013 |
Am. J. Transplant. |
pmid:23432755
|
O'Grady JG et al. |
Randomized controlled trial of tacrolimus versus microemulsified cyclosporin (TMC) in liver transplantation: poststudy surveillance to 3 years. |
2007 |
Am. J. Transplant. |
pmid:17109723
|
Böhmig GA et al. |
Immunoadsorption in severe C4d-positive acute kidney allograft rejection: a randomized controlled trial. |
2007 |
Am. J. Transplant. |
pmid:17109725
|
Ferguson R et al. |
Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients. |
2011 |
Am. J. Transplant. |
pmid:21114656
|
Hirsch HH et al. |
Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. |
2013 |
Am. J. Transplant. |
pmid:23137180
|
Mujtaba MA et al. |
Conversion from tacrolimus to belatacept to prevent the progression of chronic kidney disease in pancreas transplantation: case report of two patients. |
2014 |
Am. J. Transplant. |
pmid:25179306
|
Naesens M et al. |
Tacrolimus exposure and evolution of renal allograft histology in the first year after transplantation. |
2007 |
Am. J. Transplant. |
pmid:17608835
|
Koefoed-Nielsen PB et al. |
Blood tacrolimus levels and calcineurin phosphatase activity early after renal transplantation. |
2002 |
Am. J. Transplant. |
pmid:12099520
|
Klintmalm GB |
Immunosuppression, generic drugs and the FDA. |
2011 |
Am. J. Transplant. |
pmid:21794082
|
Shihab FS et al. |
Effect of corticosteroid withdrawal on tacrolimus and mycophenolate mofetil exposure in a randomized multicenter study. |
2013 |
Am. J. Transplant. |
pmid:23167508
|
Forns X and Navasa M |
Cyclosporine A or tacrolimus for hepatitis C recurrence? An old debate. |
2011 |
Am. J. Transplant. |
pmid:21797970
|
Alloway RR et al. |
A randomized pharmacokinetic study of generic tacrolimus versus reference tacrolimus in kidney transplant recipients. |
2012 |
Am. J. Transplant. |
pmid:22759200
|
Wlodarczyk Z et al. |
Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial. |
2009 |
Am. J. Transplant. |
pmid:19681813
|
Chisholm-Burns MA et al. |
Immunosuppressant therapy adherence and graft failure among pediatric renal transplant recipients. |
2009 |
Am. J. Transplant. |
pmid:19681814
|
Schold JD and Kaplan B |
AZA/tacrolimus is associated with similar outcomes as MMF/tacrolimus among renal transplant recipients. |
2009 |
Am. J. Transplant. |
pmid:19681827
|
Troppmann C et al. |
Impact of portal venous pancreas graft drainage on kidney graft outcome in simultaneous pancreas-kidney recipients reported to UNOS. |
2004 |
Am. J. Transplant. |
pmid:15023146
|
Pirenne J et al. |
Tolerance of liver transplant patients to strenuous physical activity in high-altitude. |
2004 |
Am. J. Transplant. |
pmid:15023147
|
Heisel O et al. |
New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. |
2004 |
Am. J. Transplant. |
pmid:15023151
|
Hardinger KL et al. |
Pharmacokinetics of tacrolimus in kidney transplant recipients: twice daily versus once daily dosing. |
2004 |
Am. J. Transplant. |
pmid:15023155
|
Suwelack B et al. |
Withdrawal of cyclosporine or tacrolimus after addition of mycophenolate mofetil in patients with chronic allograft nephropathy. |
2004 |
Am. J. Transplant. |
pmid:15023160
|
Madariaga ML et al. |
Kidney-induced cardiac allograft tolerance in miniature swine is dependent on MHC-matching of donor cardiac and renal parenchyma. |
2015 |
Am. J. Transplant. |
pmid:25824550
|
Bryan CF et al. |
Long-term survival of kidneys transplanted from live A2 donors to O and B recipients. |
2007 |
Am. J. Transplant. |
pmid:17359511
|
Vincenti F et al. |
Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. |
2007 |
Am. J. Transplant. |
pmid:17359512
|
Busque S et al. |
Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipients. |
2009 |
Am. J. Transplant. |
pmid:19660021
|
Meier-Kriesche HU et al. |
Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus. |
2005 |
Am. J. Transplant. |
pmid:16095509
|
Senior PA et al. |
Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing. |
2005 |
Am. J. Transplant. |
pmid:16095517
|
Tremblay S et al. |
A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover Study. |
2017 |
Am. J. Transplant. |
pmid:27340950
|
Hardinger KL et al. |
BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. |
2010 |
Am. J. Transplant. |
pmid:20055811
|
De Simone P et al. |
Everolimus with reduced tacrolimus in liver transplantation. |
2013 |
Am. J. Transplant. |
pmid:23601137
|
Fan DM et al. |
Successful ABO-incompatible living-related intestinal transplantation: a 2-year follow-up. |
2015 |
Am. J. Transplant. |
pmid:25808777
|
Froud T et al. |
Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. |
2005 |
Am. J. Transplant. |
pmid:15996257
|
Borrows R et al. |
Mycophenolic acid 12-h trough level monitoring in renal transplantation: association with acute rejection and toxicity. |
2006 |
Am. J. Transplant. |
pmid:16433766
|
Chodoff L and Hamberg KJ |
Response to 'Different preparations of tacrolimus and medication errors'. |
2009 |
Am. J. Transplant. |
pmid:19392982
|
Kohnle M et al. |
Ezetimibe for the treatment of uncontrolled hypercholesterolemia in patients with high-dose statin therapy after renal transplantation. |
2006 |
Am. J. Transplant. |
pmid:16433776
|
Cherukuri A et al. |
An analysis of lymphocyte phenotype after steroid avoidance with either alemtuzumab or basiliximab induction in renal transplantation. |
2012 |
Am. J. Transplant. |
pmid:22390816
|
Larson TS et al. |
Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. |
2006 |
Am. J. Transplant. |
pmid:16468960
|
Pascher A et al. |
Protein kinase C inhibitor sotrastaurin in de novo liver transplant recipients: a randomized phase II trial. |
2015 |
Am. J. Transplant. |
pmid:25677074
|
Vitko S et al. |
Tacrolimus combined with two different dosages of sirolimus in kidney transplantation: results of a multicenter study. |
2006 |
Am. J. Transplant. |
pmid:16468962
|
Barth RN et al. |
Vascularized bone marrow-based immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates. |
2011 |
Am. J. Transplant. |
pmid:21668624
|
Chen G et al. |
A synergistic effect between PG490-88 and tacrolimus prolongs renal allograft survival in monkeys. |
2006 |
Am. J. Transplant. |
pmid:16539628
|
Guirado L et al. |
Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients. |
2011 |
Am. J. Transplant. |
pmid:21668633
|
Maes BD et al. |
Differential effect of diarrhea on FK506 versus cyclosporine A trough levels and resultant prevention of allograft rejection in renal transplant recipients. |
2002 |
Am. J. Transplant. |
pmid:12484345
|
Heller T et al. |
Plasma concentrations of mycophenolic acid acyl glucuronide are not associated with diarrhea in renal transplant recipients. |
2007 |
Am. J. Transplant. |
pmid:17532750
|
Schrepfer S et al. |
Effect of inhaled tacrolimus on cellular and humoral rejection to prevent posttransplant obliterative airway disease. |
2007 |
Am. J. Transplant. |
pmid:17532751
|
Grenda R et al. |
A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study. |
2010 |
Am. J. Transplant. |
pmid:20420639
|
Knechtle SJ et al. |
Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring. |
2009 |
Am. J. Transplant. |
pmid:19344431
|
Grinyo JM et al. |
Pilot randomized study of early tacrolimus withdrawal from a regimen with sirolimus plus tacrolimus in kidney transplantation. |
2004 |
Am. J. Transplant. |
pmid:15268733
|
Pallet N et al. |
Kidney transplant recipients carrying the CYP3A4*22 allelic variant have reduced tacrolimus clearance and often reach supratherapeutic tacrolimus concentrations. |
2015 |
Am. J. Transplant. |
pmid:25588704
|
Schussler T et al. |
Severe hepatitis C infection in a renal transplant recipient following hepatitis C genotype mismatch transplant. |
2004 |
Am. J. Transplant. |
pmid:15268744
|
Min SI et al. |
Conversion of twice-daily tacrolimus to once-daily tacrolimus formulation in stable pediatric kidney transplant recipients: pharmacokinetics and efficacy. |
2013 |
Am. J. Transplant. |
pmid:23734831
|
Bunnapradist S et al. |
Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial. |
2013 |
Am. J. Transplant. |
pmid:23279614
|
Ceschi A et al. |
Acute calcineurin inhibitor overdose: analysis of cases reported to a national poison center between 1995 and 2011. |
2013 |
Am. J. Transplant. |
pmid:23279718
|
Toso C et al. |
Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol. |
2006 |
Am. J. Transplant. |
pmid:16611343
|
Lacaille F et al. |
Severe dysimmune cytopenia in children treated with tacrolimus after organ transplantation. |
2006 |
Am. J. Transplant. |
pmid:16611346
|
Chamie K et al. |
The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer. |
2008 |
Am. J. Transplant. |
pmid:18853950
|
Tedesco-Silva H et al. |
Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses. |
2015 |
Am. J. Transplant. |
pmid:25988935
|
Pech T et al. |
Intestinal regeneration, residual function and immunological priming following rescue therapy after rat small bowel transplantation. |
2012 |
Am. J. Transplant. |
pmid:22974463
|
Kaplan B and Kirk AD |
Tacrolimus and sirolimus: when bad things happen to good drugs. |
2006 |
Am. J. Transplant. |
pmid:16827845
|
McAlister VC et al. |
Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis. |
2006 |
Am. J. Transplant. |
pmid:16827858
|
Gallon L et al. |
Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF. |
2006 |
Am. J. Transplant. |
pmid:16827862
|
Grenda R et al. |
A prospective, randomized, multicenter trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation. |
2006 |
Am. J. Transplant. |
pmid:16827869
|
Vanhove T et al. |
High Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal Recipients. |
2016 |
Am. J. Transplant. |
pmid:27013142
|
Pradhan M et al. |
Decline in renal function following thoracic organ transplantation in children. |
2002 |
Am. J. Transplant. |
pmid:12201367
|
Rush D et al. |
Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study. |
2007 |
Am. J. Transplant. |
pmid:17908280
|
Lake JR et al. |
Addition of MMF to dual immunosuppression does not increase the risk of malignant short-term death after liver transplantation. |
2005 |
Am. J. Transplant. |
pmid:16303011
|
Barbas AS et al. |
Posterior reversible encephalopathy syndrome independently associated with tacrolimus and sirolimus after multivisceral transplantation. |
2013 |
Am. J. Transplant. |
pmid:23331705
|
Gatault P et al. |
Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study. |
2017 |
Am. J. Transplant. |
pmid:27862923
|
Fujishiro J et al. |
Influence of immunosuppression on alloresponse, inflammation and contractile function of graft after intestinal transplantation. |
2010 |
Am. J. Transplant. |
pmid:20642681
|
Margreiter R et al. |
Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: results of a prospective randomized trial. |
2008 |
Am. J. Transplant. |
pmid:18510632
|
Martinez F et al. |
High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF Study. |
2010 |
Am. J. Transplant. |
pmid:20642691
|